| Dr Hafez Hayek, MD | |
|
2376 Cypress Cir, Suite 100, Conway, SC 29526-8964 | |
| (843) 234-6888 | |
| (843) 234-6889 |
| Full Name | Dr Hafez Hayek |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 22 Years |
| Location | 2376 Cypress Cir, Conway, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053584888 | NPI | - | NPPES |
| 4505 | Medicaid | SC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Conway Medical Center | Conway, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Conway Hospital Inc | 7113839606 | 98 |
News Archive
With data obtained from the Virus Watch study in England and Wales, researchers found that the serial interval of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is broadly similar to estimates from previous studies and there is no evidence that the B.1.1.7 variant is associated with any change.
Orthovita, Inc.an orthobiologics and biosurgery company, is pleased to announce that Hyun W. Bae, M.D., of The Spine Institute at Saint John's Health Center in Santa Monica, California, will present an abstract entitled, Correlation of Early Pain and Long-Term Functional Results from a Multi-Center, Prospective, Randomized, Controlled FDA-IDE Vertebroplasty Trial,at the 25th Annual Meeting of the North American Spine Society (NASS) being held October 5-9, 2010 at the Orange County Convention Center in Orlando, Florida.
NexBio, Inc. announced today the publication in the Journal of Infectious Diseases of a preclinical study suggesting that treatment with DAS181 (Fludase®) may reduce the risk of secondary bacterial pneumonia following influenza virus infection.
"Malawi on Monday launched a week-long campaign to test 250,000 people for HIV in what health authorities called a crucial intervention in a country ravaged by AIDS," Agence France-Presse reports.
MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced the publication in the journal Blood of preclinical data demonstrating potent inhibition of B-cell lymphoma through redirected T lymphocyte-mediated killing, using its bispecific DART antibody technology.
› Verified 9 days ago
| Entity Name | Conway Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134172000 PECOS PAC ID: 7113839606 Enrollment ID: O20031201000111 |
News Archive
With data obtained from the Virus Watch study in England and Wales, researchers found that the serial interval of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is broadly similar to estimates from previous studies and there is no evidence that the B.1.1.7 variant is associated with any change.
Orthovita, Inc.an orthobiologics and biosurgery company, is pleased to announce that Hyun W. Bae, M.D., of The Spine Institute at Saint John's Health Center in Santa Monica, California, will present an abstract entitled, Correlation of Early Pain and Long-Term Functional Results from a Multi-Center, Prospective, Randomized, Controlled FDA-IDE Vertebroplasty Trial,at the 25th Annual Meeting of the North American Spine Society (NASS) being held October 5-9, 2010 at the Orange County Convention Center in Orlando, Florida.
NexBio, Inc. announced today the publication in the Journal of Infectious Diseases of a preclinical study suggesting that treatment with DAS181 (Fludase®) may reduce the risk of secondary bacterial pneumonia following influenza virus infection.
"Malawi on Monday launched a week-long campaign to test 250,000 people for HIV in what health authorities called a crucial intervention in a country ravaged by AIDS," Agence France-Presse reports.
MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced the publication in the journal Blood of preclinical data demonstrating potent inhibition of B-cell lymphoma through redirected T lymphocyte-mediated killing, using its bispecific DART antibody technology.
› Verified 9 days ago
| Entity Name | Hospital Physician Services - Southeast Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760410385 PECOS PAC ID: 5597774554 Enrollment ID: O20100107000067 |
News Archive
With data obtained from the Virus Watch study in England and Wales, researchers found that the serial interval of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is broadly similar to estimates from previous studies and there is no evidence that the B.1.1.7 variant is associated with any change.
Orthovita, Inc.an orthobiologics and biosurgery company, is pleased to announce that Hyun W. Bae, M.D., of The Spine Institute at Saint John's Health Center in Santa Monica, California, will present an abstract entitled, Correlation of Early Pain and Long-Term Functional Results from a Multi-Center, Prospective, Randomized, Controlled FDA-IDE Vertebroplasty Trial,at the 25th Annual Meeting of the North American Spine Society (NASS) being held October 5-9, 2010 at the Orange County Convention Center in Orlando, Florida.
NexBio, Inc. announced today the publication in the Journal of Infectious Diseases of a preclinical study suggesting that treatment with DAS181 (Fludase®) may reduce the risk of secondary bacterial pneumonia following influenza virus infection.
"Malawi on Monday launched a week-long campaign to test 250,000 people for HIV in what health authorities called a crucial intervention in a country ravaged by AIDS," Agence France-Presse reports.
MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced the publication in the journal Blood of preclinical data demonstrating potent inhibition of B-cell lymphoma through redirected T lymphocyte-mediated killing, using its bispecific DART antibody technology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hafez Hayek, MD Po Box 2180, Conway, SC 29528-2180 Ph: (843) 234-6888 | Dr Hafez Hayek, MD 2376 Cypress Cir, Suite 100, Conway, SC 29526-8964 Ph: (843) 234-6888 |
News Archive
With data obtained from the Virus Watch study in England and Wales, researchers found that the serial interval of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is broadly similar to estimates from previous studies and there is no evidence that the B.1.1.7 variant is associated with any change.
Orthovita, Inc.an orthobiologics and biosurgery company, is pleased to announce that Hyun W. Bae, M.D., of The Spine Institute at Saint John's Health Center in Santa Monica, California, will present an abstract entitled, Correlation of Early Pain and Long-Term Functional Results from a Multi-Center, Prospective, Randomized, Controlled FDA-IDE Vertebroplasty Trial,at the 25th Annual Meeting of the North American Spine Society (NASS) being held October 5-9, 2010 at the Orange County Convention Center in Orlando, Florida.
NexBio, Inc. announced today the publication in the Journal of Infectious Diseases of a preclinical study suggesting that treatment with DAS181 (Fludase®) may reduce the risk of secondary bacterial pneumonia following influenza virus infection.
"Malawi on Monday launched a week-long campaign to test 250,000 people for HIV in what health authorities called a crucial intervention in a country ravaged by AIDS," Agence France-Presse reports.
MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced the publication in the journal Blood of preclinical data demonstrating potent inhibition of B-cell lymphoma through redirected T lymphocyte-mediated killing, using its bispecific DART antibody technology.
› Verified 9 days ago
Snigdha Sharma, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2376 Cypress Cir, Ste 100, Conway, SC 29526 Phone: 843-234-6888 Fax: 843-234-6889 | |
Nikhil Baldev Patel, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 817 Farrar Dr, Conway, SC 29526 Phone: 843-234-1660 Fax: 843-234-1661 | |
Meghan Lynne Malone, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2376 Cypress Circle, Suite 203, Conway, SC 29526 Phone: 843-347-6038 Fax: 843-347-9808 | |
Dr. Richard H. Eisenman, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2376 Cypress Circle, Suite 203, Conway, SC 29526 Phone: 843-347-6038 Fax: 843-347-9808 | |
Dr. Martin A Duclos, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 300 Singleton Ridge Rd, Conway, SC 29526 Phone: 843-347-1523 Fax: 843-234-6722 | |
Dr. Richard Y Hayes, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 300 Singleton Ridge Rd, Conway, SC 29526 Phone: 843-347-1523 Fax: 843-234-6722 |